* Viveve Medical Inc VIVE.OQ VIVE.O is expected to show a
rise in quarterly revenue when it reports results on November
11.
* The Englewood, Colorado-based company is expected to report a
10.9% increase in revenue to $1.69 million from $1.52 million a
year ago, according to the mean estimate from 2 analysts, based
on Refinitiv data.
* Refinitiv's mean analyst estimate for Viveve Medical Inc is
for a loss of 61 cents per share. For the same quarter last
year, the company reported a loss of $2.60 per share.
* The current average analyst rating on the shares is "strong
buy" and the breakdown of recommendations is 2 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in the
last three months.
* Wall Street's median 12-month price target for Viveve Medical
Inc is $12.38, about 82.5% above its last closing price
of $2.17.
This summary was machine generated November 10 at 00:05 GMT.
All figures in US dollars unless otherwise stated